akso health集团

8201-4-4(A)房，前通源大厦二楼

莫斯科路44号，前湾保税港区

中国（山东）青岛自贸试验区

2024年11月26日

通过EDGAR

公司融资部

贸易与服务办公室

美国证券交易委员会

100 F街, NE

华盛顿特区，邮编20549

女士们，先生们：

谨代表Akso Health集团（一个开曼群岛免税公司）公司，特此根据1933年修订后的证券法第477条规定证券法，请求对F-3表格的登记声明修订版号1进行查阅，连同所有附件（档案编号333-252434），如已提交给美国证券交易委员会委员会:”) on November 21, 2024 (“注册声明”) be withdrawn effective immediately.

It is the Company’s understanding that this application for withdrawal of the Registration Statement will be deemed granted at the time filed with the Commission unless, within fifteen calendar days after such date, the Company receives notice from the Commission that this application will not be granted.

The Company requests, in accordance with Rule 457(p) under the Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Company’s account to be offset against the filing fee for the filing of any future registration statement or registration statements.

Accordingly, the Company hereby respectfully requests that a written order granting the withdrawal of the Registration Statement be issued by the Commission.

Should you have any questions regarding this request for withdrawal, please contact our counsel Joan Wu, Esq. of Hunter Taubman Fischer & Li LLC at (212) 530-2208, respectively.